--- title: "药明康德计划通过发行零息可转换债券筹集约 10 亿美元" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/286487023.md" description: "药明康德计划通过以美元结算的零息可转换债券筹集约 10 亿美元，以增强其产能和能力。这些债券可按初始价格 HK$153 转换为股份，约占扩大后 H 股资本的 9.1%。筹集的资金将用于全球扩展和公司用途。摩根士丹利、花旗集团和高盛正在为此次发行提供咨询" datetime: "2026-05-15T00:53:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286487023.md) - [en](https://longbridge.com/en/news/286487023.md) - [zh-HK](https://longbridge.com/zh-HK/news/286487023.md) --- # 药明康德计划通过发行零息可转换债券筹集约 10 亿美元 By Megan Cheah Wuxi AppTec plans to raise around $1 billion by issuing U.S. dollar-settled zero coupon convertible bonds, as it seeks to boost its capacity and capabilities. The Shanghai-based company, which provides drug research, development and manufacturing services, plans to issue the bonds with a principal amount of 6.78 billion yuan, equivalent to $999 million, Wuxi AppTec said Friday. The bonds can be converted to Hong Kong-listed shares at an initial conversion price of 153 Hong Kong dollars per share, or $19.54, subject to adjustments and conditions, said the company, which is listed in both Shanghai and Hong Kong. The conversion price is a premium of around 18% over Wuxi AppTec's Thursday closing price of HK$130.10, the company said. Assuming full conversion of all the bonds at this price, the converted shares will represent around 9.1% of Wuxi's enlarged H-share capital and around 1.7% of its total issued share capital. Wuxi intends to use the net proceeds of around $1.02 billion for global capacity and capability expansion, and general corporate purposes. Morgan Stanley, Citigroup and Goldman Sachs are the banks advising Wuxi on its bond issuance. Wuxi AppTec's shares in Hong Kong closed 5.2% lower at HK$130.10 on Thursday, but are about 32% higher year to date. Write to Megan Cheah at megan.cheah@wsj.com (END) Dow Jones Newswires May 14, 2026 20:41 ET (00:41 GMT) Copyright (c) 2026 Dow Jones & Company, Inc. ### 相关股票 - [02359.HK](https://longbridge.com/zh-CN/quote/02359.HK.md) - [159892.CN](https://longbridge.com/zh-CN/quote/159892.CN.md) - [512010.CN](https://longbridge.com/zh-CN/quote/512010.CN.md) - [520880.CN](https://longbridge.com/zh-CN/quote/520880.CN.md) - [159570.CN](https://longbridge.com/zh-CN/quote/159570.CN.md) - [159837.CN](https://longbridge.com/zh-CN/quote/159837.CN.md) - [516500.CN](https://longbridge.com/zh-CN/quote/516500.CN.md) - [562050.CN](https://longbridge.com/zh-CN/quote/562050.CN.md) - [516930.CN](https://longbridge.com/zh-CN/quote/516930.CN.md) - [512290.CN](https://longbridge.com/zh-CN/quote/512290.CN.md) - [520500.CN](https://longbridge.com/zh-CN/quote/520500.CN.md) - [603259.CN](https://longbridge.com/zh-CN/quote/603259.CN.md) - [MS.US](https://longbridge.com/zh-CN/quote/MS.US.md) - [C.US](https://longbridge.com/zh-CN/quote/C.US.md) - [GS.US](https://longbridge.com/zh-CN/quote/GS.US.md) - [MS-O.US](https://longbridge.com/zh-CN/quote/MS-O.US.md) - [MS-Q.US](https://longbridge.com/zh-CN/quote/MS-Q.US.md) - [MS-E.US](https://longbridge.com/zh-CN/quote/MS-E.US.md) - [MS-I.US](https://longbridge.com/zh-CN/quote/MS-I.US.md) - [MS-L.US](https://longbridge.com/zh-CN/quote/MS-L.US.md) - [MS-P.US](https://longbridge.com/zh-CN/quote/MS-P.US.md) - [MS-A.US](https://longbridge.com/zh-CN/quote/MS-A.US.md) - [MS-F.US](https://longbridge.com/zh-CN/quote/MS-F.US.md) - [MS-K.US](https://longbridge.com/zh-CN/quote/MS-K.US.md) - [C-R.US](https://longbridge.com/zh-CN/quote/C-R.US.md) - [W4VR.SG](https://longbridge.com/zh-CN/quote/W4VR.SG.md) ## 相关资讯与研究 - [药明康德建议发行人民币 67.8 亿元于 2027 年到期的美元结算零息可转换债券](https://longbridge.com/zh-CN/news/286482748.md) - [药明康德拟发行 67.8 亿元人民币 以美元结算零息可转换债券](https://longbridge.com/zh-CN/news/286487175.md) - [药明康德零息美元可转债强势定价：零利息且需 “倒贴 3.5%”](https://longbridge.com/zh-CN/news/286486297.md) - [玮俊生物科技股东将股票存入马银证券 (香港) 存仓市值 2002.50 万港元](https://longbridge.com/zh-CN/news/286485658.md) - [2025 年 CXO 行业净利暴增 85%，从 “烧钱扩产” 到 “技术致胜”，最残酷的洗牌已经开始](https://longbridge.com/zh-CN/news/286279953.md)